Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 10
Submit an article Journal homepage
161
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in Australia

Abby P. DouglasDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-8314-352X
ORCID Icon,
Karin A. ThurskyDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Victorian Infectious Diseases Service, The Peter Doherty Institute for Immunity and Infection, Royal Melbourne Hospital, Melbourne, Australia; ;National Centre for Antimicrobial Stewardship, Melbourne, Australia; ORCID Iconhttp://orcid.org/0000-0002-7400-232X
ORCID Icon,
Leon J. WorthDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; ;National Centre for Antimicrobial Stewardship, Melbourne, Australia; ORCID Iconhttp://orcid.org/0000-0003-4304-6845
ORCID Icon,
Simon James HarrisonSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Department of Haematology, Royal Melbourne Hospital, Melbourne, Australia; ORCID Iconhttp://orcid.org/0000-0003-4555-6582
ORCID Icon,
Rod John HicksSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, AustraliaORCID Iconhttp://orcid.org/0000-0002-0758-0824
ORCID Icon &
Monica A. SlavinDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Victorian Infectious Diseases Service, The Peter Doherty Institute for Immunity and Infection, Royal Melbourne Hospital, Melbourne, Australia; ORCID Iconhttp://orcid.org/0000-0002-8443-314X
ORCID Icon
Pages 2471-2476 | Received 02 Nov 2018, Accepted 26 Feb 2019, Published online: 05 Apr 2019
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Abstract

PET/CT is useful for investigation of neutropenic fever (NF) and potential invasive fungal infection (IFI) in those with hematological malignancies (HM). An online survey evaluating the utility and current practices regarding PET/CT scanning for investigation of NF was distributed to infectious diseases (ID) clinicians and hematologists via email lists hosted by key professional bodies. One-hundred and forty-five clinicians responded (120 ID; 25 hematologists). Access to PET/CT was fair but timeliness of investigation was limited (within 3 days in 35% and 46% of ID and hematology respondents, respectively). Among those with experience with PET/CT for infection (n = 109), 40% had utilized PET/CT for prolonged NF and 20% for diagnosing IFI. The majority of respondents indicated the desire to utilize PET/CT more frequently for infection indications. There is a strong desire among surveyed Australian clinicians to use PET/CT for prolonged NF and potential IFI. However, access to PET/CT is a current barrier to uptake.

Acknowledgments

We thank Professor Sharon Chen, and Dr Alan Street and Dr Louise Cooley for their contributions to the survey. We also thank the Australasian Leukemia and Lymphoma Group and the Haematology Society of Australia and New Zealand for their kind distribution of the survey.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2019.1590571.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.